Literature DB >> 18217751

Optimization of activity-based probes for proteomic profiling of histone deacetylase complexes.

Cleo M Salisbury1, Benjamin F Cravatt.   

Abstract

Histone deacetylases (HDACs) are key enzymatic regulators of the epigenome and serve as promising targets for anticancer therapeutics. Recently, we developed a photoreactive "clickable" probe, SAHA-BPyne, to report on HDAC activity and complex formation in native biological systems. Here, we investigate the selectivity, sensitivity, and inhibitory properties of SAHA-BPyne and related potential activity-based probes for HDACs. While we identified several probes that are potent HDAC inhibitors and label HDAC complex components in native proteomic preparations, SAHA-BPyne was markedly superior for profiling HDAC activities in live cells. Interestingly, the enhanced performance of SAHA-BPyne as an in situ activity-based probe could not be solely ascribed to potency in HDAC binding, implying that other features of the molecule were key to efficient active site-directed labeling in living systems. Finally, we demonstrate the value of in situ profiling of HDACs by comparing the activity and expression of HDAC1 in cancer cells treated with the cytotoxic agent parthenolide. These results underscore the utility of activity-based protein profiling for studying HDAC function and may provide insight for the future development of click chemistry-based photoreactive probes for the in situ analysis of additional enzyme activities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18217751     DOI: 10.1021/ja074138u

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  39 in total

Review 1.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Design, synthesis, modeling, biological evaluation and photoaffinity labeling studies of novel series of photoreactive benzamide probes for histone deacetylase 2.

Authors:  Aditya Sudheer Vaidya; Bhargava Karumudi; Emma Mendonca; Antonett Madriaga; Hazem Abdelkarim; Richard B van Breemen; Pavel A Petukhov
Journal:  Bioorg Med Chem Lett       Date:  2012-06-18       Impact factor: 2.823

3.  Strategies for discovering and derisking covalent, irreversible enzyme inhibitors.

Authors:  Douglas S Johnson; Eranthie Weerapana; Benjamin F Cravatt
Journal:  Future Med Chem       Date:  2010-06       Impact factor: 3.808

Review 4.  Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitors.

Authors:  Daiqing Liao
Journal:  Drug Discov Today Technol       Date:  2015-11-03

5.  How chemoproteomics can enable drug discovery and development.

Authors:  Raymond E Moellering; Benjamin F Cravatt
Journal:  Chem Biol       Date:  2012-01-27

Review 6.  Chemical probes for histone-modifying enzymes.

Authors:  Philip A Cole
Journal:  Nat Chem Biol       Date:  2008-10       Impact factor: 15.040

7.  Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencing.

Authors:  Chunping Xu; Elisabetta Soragni; C James Chou; David Herman; Heather L Plasterer; James R Rusche; Joel M Gottesfeld
Journal:  Chem Biol       Date:  2009-09-25

8.  Peptide arrays identify isoform-selective substrates for profiling endogenous lysine deacetylase activity.

Authors:  Zachary A Gurard-Levin; Kristopher A Kilian; Joohoon Kim; Katinka Bähr; Milan Mrksich
Journal:  ACS Chem Biol       Date:  2010-09-17       Impact factor: 5.100

9.  Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides.

Authors:  Christian A Olsen; M Reza Ghadiri
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

10.  Non-peptide macrocyclic histone deacetylase inhibitors.

Authors:  Adegboyega K Oyelere; Po C Chen; William Guerrant; Sandra C Mwakwari; Rebecca Hood; Yunzhe Zhang; Yuhong Fan
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.